³Ô¹Ï±¬ÁÏ

Skip to content
Contact Sales 866-417-3024

Regions

North America

Europe

EN | DE | ES | FR | IT

°ä³ó¾±²Ô²¹&²Ô²ú²õ±è;Öйú

´³²¹±è²¹²Ô&²Ô²ú²õ±è;ÈÕ±¾

Asia Pacific

Korea

Latin America

PORTUGUESE | SPANISH

Industries

Life Sciences

MedTech

³Ô¹Ï±¬ÁÏ Logo
  • ³Ô¹Ï±¬ÁÏ
    • Clinical Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ Clinical Platform
      • Clinical Operations
      • ³Ô¹Ï±¬ÁÏ eTMFStay inspection ready
      • ³Ô¹Ï±¬ÁÏ CTMSManage trials end-to-end
      • ³Ô¹Ï±¬ÁÏ PaymentsPay clinical research sites faster
      • ³Ô¹Ï±¬ÁÏ Study StartupAccelerate site activation
      • ³Ô¹Ï±¬ÁÏ RTSMRandomization and supply management
      • ³Ô¹Ï±¬ÁÏ Site ConnectAutomate information sharing
      • ³Ô¹Ï±¬ÁÏ Study TrainingStreamline and automate training
      • ³Ô¹Ï±¬ÁÏ DisclosuresCentralize clinical trial disclosures
      • ³Ô¹Ï±¬ÁÏ OpenData ClinicalProvide investigator and site data
      • Clinical Data
      • ³Ô¹Ï±¬ÁÏ EDCCollect and verify site data
      • ³Ô¹Ï±¬ÁÏ DQSAggregate and clean study data
      • ³Ô¹Ï±¬ÁÏ eCOACapture patient data
      • Patient Experience
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Regulatory Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ RIM
      • ³Ô¹Ï±¬ÁÏ RegistrationsTrack global registrations
      • ³Ô¹Ï±¬ÁÏ SubmissionsPlan and manage submissions
      • ³Ô¹Ï±¬ÁÏ Submissions PublishingPublish to health authorities
      • ³Ô¹Ï±¬ÁÏ Submissions ArchiveAccess submissions history
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Safety Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ Safety Suite
      • ³Ô¹Ï±¬ÁÏ SafetyAdverse Event management
      • ³Ô¹Ï±¬ÁÏ SafetyDocsManage safety content
      • ³Ô¹Ï±¬ÁÏ Safety WorkbenchAdvanced reporting and analysis
      • ³Ô¹Ï±¬ÁÏ Safety SignalSignal detection and management
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Quality Solutions
      • ³Ô¹Ï±¬ÁÏ Quality Cloud
      • Quality Assurance
      • ³Ô¹Ï±¬ÁÏ QMSManage all quality processes in one place
      • ³Ô¹Ï±¬ÁÏ QualityDocsGain control of GxP documents
      • ³Ô¹Ï±¬ÁÏ Validation ManagementManage and execute paperless validation
      • ³Ô¹Ï±¬ÁÏ Batch ReleaseSpeed release decisions with confidence
      • ³Ô¹Ï±¬ÁÏ Product SurveillanceSimplify postmarket surveillance for medical devices
      • ³Ô¹Ï±¬ÁÏ Station ManagerDeliver right content to the right station
      • Training
      • ³Ô¹Ï±¬ÁÏ TrainingEnsure role-based qualification and compliance
      • Quality Control
      • ³Ô¹Ï±¬ÁÏ LIMSOptimize QC labs to increase efficiency
      • Health and Safety
      • ³Ô¹Ï±¬ÁÏ EHSManage environmental, health, and safety processes
      • Contract Services Organizations
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Medical Suite
      • ³Ô¹Ï±¬ÁÏ Medical Suite
      • Operations
      • ³Ô¹Ï±¬ÁÏ PublicationsPlan, author, and manage publications
      • ³Ô¹Ï±¬ÁÏ MedCommsCentralize and scale medical content
      • ³Ô¹Ï±¬ÁÏ MedInquiryStreamline inquiry intake and fulfillment
      • Engagement
      • Medical CRMDrive high-impact scientific exchange
      • ³Ô¹Ï±¬ÁÏ Link Key PeopleGet deep data on KOLs and their ecosystems
      • ³Ô¹Ï±¬ÁÏ Link WorkflowManage KOL engagement workflows
      • Insights
      • ³Ô¹Ï±¬ÁÏ Link Medical InsightsAccelerate insights from capture to action
      • Measuring Medical Impact
      • Reimagine Medical Engagement
      • Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Commercial Solutions
      • ³Ô¹Ï±¬ÁÏ Commercial Solutions
      • Commercial Evidence?Transform field and digital interactions into actionable insights
      • Software
      • CRM SuiteCoordinated agentic engagement across channels
      • Campaign ManagerSynchronized sales and marketing
      • Events ManagementLive, virtual, and hybrid events
      • AlignTerritory, roster, and engagement planning
      • Patient CRMPatient support and engagement
      • ContentCompliant content at scale
      • Marketing AnalyticsCampaign measurement, targeting, and insights
      • Data Science and Analytics PlatformIntegrated commercial data for faster insights
      • Network MDMStandardized master data management
      • Data
      • Global Reference DataComplete HCP and HCO profiles
      • Global HCP DataHCP access data
      • Global Deep DataKOL profiles and key account data
      • U.S. Performance DataHigh-quality patient, prescriber, and national data
      • Services
      • Business ConsultingStrategic advisory services
    • Data Solutions
      • ³Ô¹Ï±¬ÁÏ Data Cloud
      • Global Reference Data
      • ³Ô¹Ï±¬ÁÏ OpenData CommercialComplete HCP and HCO profiles
      • ³Ô¹Ï±¬ÁÏ OpenData ClinicalAccurate site and investigator data
      • Global HCP Data
      • ³Ô¹Ï±¬ÁÏ HCP AccessHCP access data
      • Global Deep Data
      • ³Ô¹Ï±¬ÁÏ Link Key PeopleDeep data on KOLs
      • ³Ô¹Ï±¬ÁÏ Link Key AccountsDeep data on key accounts
      • U.S. Performance Data
      • ³Ô¹Ï±¬ÁÏ Compass PatientAnonymous patient longitudinal data
      • ³Ô¹Ï±¬ÁÏ Compass PrescriberHCP, HCO, and ZIP projected data
      • ³Ô¹Ï±¬ÁÏ Compass NationalState and national projected data
      • Services
      • ³Ô¹Ï±¬ÁÏ AnalyticsStrategic advisory services
    • Vault AI
      • Vault AI
      • Vault AI
      • Agentic AIBuilt into Vault Platform
      • AI AgentsDeploy standard and custom agents
      • Vault Platform
    • Research Site Solutions
    • Industries
      • Industries
      • Pharma & BiotechR&D, quality, medical, and commercial solutions
      • Consumer HealthSolutions from clinical to commercial
      • Animal HealthTailored applications for animal health
      • MedTechStreamline content and data management
  • Services
    • Services
    • Business Consulting
    • Analytics
    • ³Ô¹Ï±¬ÁÏ Digital Events
    • Partners
    • Services Partners
    • Product Partners
    • AI Partners
    • Content Partners
    • CRO Partners
    • Data Partners
  • Customers
  • Resources
  • Events
  • About ³Ô¹Ï±¬ÁÏ
    • About ³Ô¹Ï±¬ÁÏ
    • Leadership
    • Public Benefit Corporation
    • Corporate Citizenship
    • Diversity at ³Ô¹Ï±¬ÁÏ
    • Partners
    • Trust
    • Recent University Graduates
    • News
    • Announcements
    • Press Coverage
    • ³Ô¹Ï±¬ÁÏ Blog
    • Contact Us
  • Contact Us
  • ³Ô¹Ï±¬ÁÏ Logo
  • ³Ô¹Ï±¬ÁÏ
      Clinical
      Regulatory
      Safety
      Quality
      Medical
      Commercial
      Data
      Vault AI
      Research Sites
      Industries
      Demo Center
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ Clinical Platform
      Clinical Operations
      ³Ô¹Ï±¬ÁÏ eTMF

      Stay inspection ready

      ³Ô¹Ï±¬ÁÏ CTMS

      Manage trials end-to-end

      ³Ô¹Ï±¬ÁÏ Payments

      Pay clinical research sites faster

      ³Ô¹Ï±¬ÁÏ Study Startup

      Accelerate site activation

      ³Ô¹Ï±¬ÁÏ RTSM

      Randomization and supply management

      ³Ô¹Ï±¬ÁÏ Site Connect

      Automate information sharing

      ³Ô¹Ï±¬ÁÏ Study Training

      Streamline and automate training

      ³Ô¹Ï±¬ÁÏ Disclosures

      Centralize clinical trial disclosures

      ³Ô¹Ï±¬ÁÏ OpenData Clinical

      Provide investigator and site data

      Clinical Data
      ³Ô¹Ï±¬ÁÏ EDC

      Collect and verify site data

      ³Ô¹Ï±¬ÁÏ DQS

      Aggregate and clean study data

      ³Ô¹Ï±¬ÁÏ eCOA

      Capture patient data

      Learn About the Patient Experience
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ RIM
      ³Ô¹Ï±¬ÁÏ Registrations

      Track global registrations

      ³Ô¹Ï±¬ÁÏ Submissions

      Plan and manage submissions

      ³Ô¹Ï±¬ÁÏ Submissions Publishing

      Publish to health authorities

      ³Ô¹Ï±¬ÁÏ Submissions Archive

      Access submissions history

      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ Safety Suite
      ³Ô¹Ï±¬ÁÏ Safety

      Adverse Event management

      ³Ô¹Ï±¬ÁÏ SafetyDocs

      Manage safety content

      ³Ô¹Ï±¬ÁÏ Safety Workbench

      Advanced reporting and analysis

      ³Ô¹Ï±¬ÁÏ Safety Signal

      Signal detection and management

      Are you an emerging or clinical biotech? Learn More
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      Are you a CRO? Learn more
      VEEVA QUALITY CLOUD
      Quality Assurance
      ³Ô¹Ï±¬ÁÏ QMS

      Manage all quality processes in one place

      ³Ô¹Ï±¬ÁÏ QualityDocs

      Gain control of GxP documents

      ³Ô¹Ï±¬ÁÏ Validation Management

      Manage and execute paperless validation

      ³Ô¹Ï±¬ÁÏ Batch Release

      Speed release decisions with confidence

      ³Ô¹Ï±¬ÁÏ Product Surveillance

      Simplify postmarket surveillance for medical devices

      ³Ô¹Ï±¬ÁÏ Station Manager

      Deliver right content to the right station

      Training
      ³Ô¹Ï±¬ÁÏ Training

      Ensure role-based qualification and compliance

      Quality Control
      ³Ô¹Ï±¬ÁÏ LIMS

      Optimize QC labs to increase efficiency

      Health and Safety
      ³Ô¹Ï±¬ÁÏ EHS

      Manage environmental, health, and safety processes

      Are you a contract services organization? Learn More
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      ³Ô¹Ï±¬ÁÏ Medical Suite
      Operations
      ³Ô¹Ï±¬ÁÏ Publications

      Plan, author, and manage publications

      ³Ô¹Ï±¬ÁÏ MedComms

      Centralize and scale medical content

      ³Ô¹Ï±¬ÁÏ MedInquiry

      Streamline inquiry intake and fulfillment

      Insights
      ³Ô¹Ï±¬ÁÏ Link Medical Insights

      Accelerate insights from capture to action

      Engagement
      Medical CRM

      Drive high-impact scientific exchange

      ³Ô¹Ï±¬ÁÏ Link Key People

      Get deep data on KOLs and their ecosystems

      ³Ô¹Ï±¬ÁÏ Link Workflow

      Manage KOL engagement workflows

      Measuring Medical Impact
      Reimagine Medical Engagement
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA COMMERCIAL SOLUTIONS
      Commercial Evidence™

      Transform field and digital interactions into actionable insights

      Software
      CRM Suite

      Coordinated agentic engagement across channels

      Campaign Manager

      Synchronized sales and marketing

      Events Management

      Live, virtual, and hybrid events

      Align

      Territory, roster, and engagement planning

      Patient CRM

      Patient support and engagement

      Content

      Compliant content at scale

      Marketing Analytics

      Campaign measurement, targeting, and insights

      Data Science and Analytics Platform

      Integrated commercial data for faster insights

      Network MDM

      Standardized master data management

      Data
      Global Reference Data

      Complete HCP and HCO profiles

      Global HCP Data

      HCP access data

      Global Deep Data

      KOL profiles and key account data

      U.S. Performance Data

      Patient and prescriber data

      Services
      Business Consulting

      Strategic advisory services


      By Need
      Achieve Agentic Commercial
      Increase Omnichannel Impact
      Agentic AI for MLR
       
      Segmentation & Targeting
      DTC Advertising
      Launch Excellence
      VEEVA DATA CLOUD
      Global Reference Data
      ³Ô¹Ï±¬ÁÏ OpenData Commercial

      Complete HCP and HCO profiles

      ³Ô¹Ï±¬ÁÏ OpenData Clinical

      Accurate site and investigator data

      Global HCP Data
      ³Ô¹Ï±¬ÁÏ HCP Access

      HCP access data

      Global Deep Data
      ³Ô¹Ï±¬ÁÏ Link Key People

      Deep data on KOLs

      ³Ô¹Ï±¬ÁÏ Link Key Accounts

      Deep data on key accounts

      U.S. Performance Data
      ³Ô¹Ï±¬ÁÏ Compass Patient

      Anonymous patient longitudinal data

      ³Ô¹Ï±¬ÁÏ Compass Prescriber

      HCP, HCO, and ZIP projected data

      ³Ô¹Ï±¬ÁÏ Compass National

      State and national projected data

      Services
      ³Ô¹Ï±¬ÁÏ Analytics

      Strategic advisory services


      By Need
      Achieve Agentic Commercial
      Deepen Your Customer Insights
      Tailor Content at Scale
       
      Increase Omnichannel Impact
      Drive Launch Excellence

      By Need
      Segmentation & Targeting
      FOR VAULT PLATFORM
      & VEEVA APPLICATIONS
      Vault AI
      Agentic AI

      Built into Vault Platform

      AI Agents

      Deploy standard and custom agents

      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      Industries
      Pharma & Biotech

      R&D, quality, medical, and commercial solutions

      Consumer Health

      Solutions from clinical to commercial

      Animal Health

      Tailored applications for animal health

      MedTech

      Streamline content and data management

      Demo Center
      AI (³Ô¹Ï±¬ÁÏ AI)

      Clinical Operations

      Clinical Data

      Regulatory

      Safety

      Development Cloud

      Quality

      Commercial

      Medical

      Data

  • Services
      Services
      Business Consulting
      Analytics
      ³Ô¹Ï±¬ÁÏ Digital Events
      Partners
      Services Partners
      Product Partners
      AI Partners
      Content Partners
      CRO Partners
      Data Partners
  • Customers
  • Resources
  • Events
  • About ³Ô¹Ï±¬ÁÏ
      About ³Ô¹Ï±¬ÁÏ
      Leadership
      Public Benefit Corporation
      Corporate Citizenship
      Diversity at ³Ô¹Ï±¬ÁÏ
      Partners
      Trust
      Recent University Graduates
      News
      Announcements
      Press Coverage
      ³Ô¹Ï±¬ÁÏ Blog
      Contact Us
Industry Report

³Ô¹Ï±¬ÁÏ Pulse Field Trends Report Q4 2022

Digital content more than doubles promotional response.

Download Top Insights
Table of Contents

Digital Content More Than Doubles Promotional Response

When sales reps share digital content during meetings with healthcare professionals (HCPs) it has a measurable promotional impact ¨C but more than 60% of rep-HCP interactions miss the opportunity. New ³Ô¹Ï±¬ÁÏ Pulse data shows that focusing on high-impact content and training your field team on effective usage can improve commercial success.

³Ô¹Ï±¬ÁÏ Pulse data ¨C the largest ever analysis of 600 million annual HCP-rep interactions globally across more than 80% of the industry ¨C for Q4 2022 reveals that:

  1. Sales rep calls that share digital content drive 2.5x new patient starts over calls that don¡¯t share content.
  2. Globally, field teams share digital content in just 39% of meetings, underscoring the opportunity to use content more frequently and effectively.
  3. Field teams that use content the most outpace lagging companies at a rate of 4:1, a significant competitive advantage.
  4. Even though biopharmas created 20% more content over the previous year, 77% of that content is rarely or never used by field teams.

Although this data shows that content can and should be used more widely to engage HCPs, creating more content isn¡¯t the answer ¨C in fact, it could be slowing you down. This is why leading biopharmas are focusing on content assets with high field buy-in and a measurable impact on HCP engagement to drive commercial success.

Read on for ³Ô¹Ï±¬ÁÏ Business Consulting¡¯s in-depth analysis of content usage and recommended actions.

Thank you,

Dan Rizzo

Vice President, Business Consulting, ³Ô¹Ï±¬ÁÏ


Digital content usage drives 2.5x new patient starts

As detailed in previous Pulse reports, HCP access is better than you might think, but it can still be a challenge for biopharma field reps to reach target HCPs. Once they do, making the most of these limited opportunities is essential for commercial success.

³Ô¹Ï±¬ÁÏ Pulse and Compass data show that sharing digital content during HCP meetings drives new patient starts 2.5x more than meetings that don¡¯t use it. This increased promotional impact is consistent across both in-person and video channels.

Digital content sharing has benefits beyond educating HCPs on the scientific evidence supporting a given treatment and answering common questions. It¡¯s also an effective way to extend meeting duration, create opportunities for follow-up touchpoints via digital channels, and give your team valuable, measurable data on content effectiveness.

Promotional impact of digital content

In-person and video meetings

Content leaders outpace laggards by 4:1

Despite the clear benefits of digital content sharing, global field teams only use it in 39% of HCP meetings on average. ³Ô¹Ï±¬ÁÏ Pulse data also shows a wide gap between companies that use content the most vs. companies that use it the least. The top three organizations use content in nearly 70% of meetings, compared to just 18% for the bottom three organizations, nearly a 4:1 difference.

Percent of rep-HCP meetings using digital content

In-person and video

Because digital content is shown to have a clear promotional impact, using it effectively is a competitive advantage. Field teams should benchmark their digital content usage against their competitors to identify gaps in their content strategy. Modular content, for example, is just one way to optimize your content factory by balancing personalization with speed and scale.

Content quality is more important than quantity

The pandemic put omnichannel marketing strategies ¨C including content ¨C into overdrive. But even as the pandemic wanes, content production continues to increase. Globally, biopharmas created 20% more content in 2022 vs. 2021, with little signs of slowing down. Much of this content ¨C and the resources needed to create it ¨C are wasted.

³Ô¹Ï±¬ÁÏ Pulse data shows that 77% of field content is never or rarely used. An analysis of slide presentations shown by sales reps during meetings with HCPs shows that the average meeting uses less than four slides. Those few slides, however, can still carry a major promotional impact.

Biopharmas should focus their content strategy on fewer content assets that have high field buy-in, get used more frequently, and create impactful discussions with HCPs. This approach can eliminate unused content and redirect resources to training and creating high-impact content that resonates with HCPs. This is a key reason companies like Sanofi are building content strategies that deliver more connected, personalized HCP experiences.

Reach out to ³Ô¹Ï±¬ÁÏ Business Consulting to find out how you can use this industry data to measure your content strategy relative to the industry, improve field execution, and achieve commercial excellence.


Global and Regional Trends

This report highlights global and regional field engagement trends from ³Ô¹Ï±¬ÁÏ Pulse data between April and December 2022. ³Ô¹Ï±¬ÁÏ Pulse data is sourced from ³Ô¹Ï±¬ÁÏ¡¯s aggregated CRM activity dataset, inclusive of field engagement stats from all instances of ³Ô¹Ï±¬ÁÏ CRM globally. This report also includes insights from ³Ô¹Ï±¬ÁÏ Pulse Content Metrics, the first and only industry benchmark for commercial content performance based on real-world, anonymized data collected across 350+ global pharma companies.

Global trends
U.S. market trends
Europe market trends
Asia market trends
Latin America market trends

Global trends

  • In-person meetings (76%) create the foundation for HCP engagement, with virtual channels (24%) extending the conversation (Figure 2).
  • Although just 3% of the channel mix, video engagement effectively lengthens meetings and enables content sharing.
  • ³Ô¹Ï±¬ÁÏ CRM Engage meetings averaged 19 minutes and had 85% content usage (Figures 7 and 8).
  • Asia and Latin America continued to have the highest volume of interactions (Figure 3), and video usage was highest in Asia with three video meetings per rep per week.
  • Content review times fluctuated significantly around the holidays (Figure 9), with an annual low in November (13.5 days) and a new high (17 days) at the end of the year.
  • Content drives HCP engagement and promotional response; MLR forecasting and resource capacity planning are critical to ensure timely approval during slow periods.

Figure 1: Channel mix evolution

Figure 2: Channel mix

Global field team activity Weekly activity per user by engagement channel

Figure 3: Activity by region

Figure 4: Activity by user type

Figure 5: Activity by company size


Global engagement quality Consolidation of key quality metrics

Figure 6: Approved email volume

Figure 7: Content usage by channel

Figure 8: Engage meeting duration

Global content production Speed and efficiency metrics

Figure 9: Days in review, global

Figure 10: Days to approval, global

Figure 11: Number of review cycles, global
Global trends
U.S. market trends
Europe market trends
Asia market trends
Latin America market trends

U.S. market trends

  • The U.S. channel mix was 71% in-person and 29% virtual (Figure 13). Despite a small decline via CRM Engage video, content usage rose slightly via in-person and other video platforms (Figure 18).
  • CLM usage effectively increases HCP engagement, drives message retention, and generates insights across channels.
  • U.S. tied with Asia for longest customer meetings (16-minute average within ³Ô¹Ï±¬ÁÏ CRM Engage calls) but had the lowest number of sales rep activities per week (Figure 15).
  • U.S. phone, video, and email productivity lags behind other regions. U.S. reps should consider opportunities to increase digital channel usage.
  • Content review and approval times in the U.S. remained steady, despite a holiday spike when reviews rose to nearly 25 days and approvals to 33 days (Figures 20 and 21).
  • The U.S. has longer content approval times than other major regions; an agile approach ¡ª such as modular content ¡ª can improve speed to market.

Figure 12: Channel mix evolution, U.S.

Figure 13: Channel mix, U.S.

U.S. field team activity Weekly activity per user by engagement channel

Figure 14: Activity, U.S.

Figure 15: Activity by user type

Figure 16: Activity by company size


U.S. engagement quality Consolidation of key quality metrics

Figure 17: Approved email volume, U.S.

Figure 18: Content usage by channel, U.S.

Figure 19: Engage meeting, U.S.

U.S. content production Speed and efficiency metrics

Figure 20: Days in review, U.S.

Figure 21: Days to approval, U.S.

Figure 22: Number of review cycles, U.S.
Global trends
U.S. market trends
Europe market trends
Asia market trends
Latin America market trends

Europe market trends

  • The channel mix in Europe was consistent from the last quarter; however, in-person interactions (65%) were substantially lower than the global average (Figure 24).
  • Germany led the region in email usage at 18 per user per week, and Spain led in-person touchpoints with 45 meetings per user per week (Figure 25).
  • With large degrees of variation in engagement trends, a data-driven approach can optimize HCP engagement strategies for regional preferences.
  • Remote meeting duration was lower than in other regions, but CLM usage increased across all channels, including an in-person peak of 30% CLM usage (Figure 29).
  • Content speed and efficiency improved across Europe. Although the number of review cycles remained consistent, this quarter recorded some of the shortest days to approval (less than 20 days) and days in review (12 days) since April 2022 (Figures 31 and 32).
  • Content reuse and modular content strategies can shorten review and approval cycles.

Figure 23: Channel mix evolution, Europe

Figure 24: Channel mix, Europe

Europe field team activity Weekly activity per user by engagement channel

Figure 25: Activity by country, EU5

Figure 26: Activity by user type

Figure 27: Activity by company size


Europe engagement quality Consolidation of key quality metrics

Figure 28: Approved email volume, Europe

Figure 29: Content usage by channel, Europe

Figure 30: Engage meeting duration, Europe

Europe content production Speed and efficiency metrics

Figure 31: Days in review, Europe

Figure 32: Days to approval, Europe

Figure 33: Number of review cycles, Europe
Global trends
U.S. market trends
Europe market trends
Asia market trends
Latin America market trends

Asia market trends

  • Asia had the highest use of CLM during engagements globally, and usage continued to rise this quarter.
  • Over 60% of video calls leveraged CLM in the last week of December (Figure 40).
  • Asia had some of the longest virtual meetings at 16 minutes (Figure 41) and the highest approved email open rates at 50% (Figure 39), suggesting organizations are adept at building a high volume of content that resonates with customers.
  • Asia brought content to market faster than any other region (Figure 43), demonstrating an efficient content model.
  • The Philippines had the highest video productivity (eight per user per week) and chat or text (seven per user per week) usage of the five major Asian countries (Figure 36), showcasing the potential of digital channels in this region.
  • High digital channel usage increased productivity in this market, outpacing the average of 47 total interactions per sales rep per week.

Figure 34: Channel mix evolution, Asia

Figure 35: Channel mix, Asia

Asia field team activity Weekly activity per user by engagement channel

Figure 36: Activity by country, Asia

Figure 37: Activity by user type

Figure 38: Activity by company size


Asia engagement quality Consolidation of key quality metrics

Figure 39: Approved email volume, Asia

Figure 40: Content usage by channel, Asia

Figure 41: Engage meeting duration, Asia

Asia content production Speed and efficiency metrics

Figure 42: Days in review, Asia

Figure 43: Days to approval, Asia

Figure 44: Number of review cycles, Asia
Global trends
U.S. market trends
Europe market trends
Asia market trends
Latin America market trends

Latin America market trends

  • The main HCP engagement channels in Latin America were in-person and email.
  • Sales reps leveraged chat and text at a higher rate (2%) than the global average (Figure 46), indicating that HCPs in this region are open to more personalized engagement.
  • Medical users leveraged chat, text, and video channels as a larger percentage of their channel mix than sales and KAM users (Figure 48), underscoring how digital channels can drive scientific conversations with HCPs across broader geographies.
  • Approved email volumes and open rates declined throughout the quarter (Figure 50), while content approval times steadily increased (Figure 54).
  • This correlation suggests the decline in approved email could be related to lagging approvals, creating a shortage of new content and underscoring the need for efficient content processes.

Figure 45: Channel mix evolution, Latin America

Figure 46: Channel mix, Latin America

Latin America field team activity Weekly activity per user by engagement channel

Figure 47: Activity by country, Latin America

Figure 48: Activity by user type

Figure 49: Activity by company size


Latin America engagement quality Consolidation of key quality metrics

Figure 50: Approved email volume, Latin America

Figure 51: Content usage by channel, Latin America

Figure 52: Engage meeting duration, Latin America

Latin America content production Speed and efficiency metrics

Figure 53: Days in review, Latin America

Figure 54: Days to approval, Latin America

Figure 55: Number of review cycles, Latin America

Appendix: Data dictionary

Metric definitions

  • Channel mix evolution over time: Weekly ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat, or text)
  • Q4 channel mix: Total ³Ô¹Ï±¬ÁÏ CRM activity volume for October, November, and December 2022, broken down by engagement channel percentage
  • Weekly activities per user: The average weekly number of ³Ô¹Ï±¬ÁÏ CRM activities submitted per number of users active in ³Ô¹Ï±¬ÁÏ CRM
  • Approved email volume: Volume of approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email open rate: Percentage of approved emails opened at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email click rate: Percentage of approved emails clicked at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • In-person % CLM usage: Percentage of in-person engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Video % CLM usage: Percentage of video engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Engage meeting % CLM usage: Percentage of Engage meetings that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Engage meeting duration: The average duration of Engage meetings in minutes
  • Days to approval: The average total number of days it takes a document from initial upload/placeholder creation to be fully Approved for Distribution (Total Time to Market)
  • Days in review: The average total number of days it takes a document from the first time it is sent for MLR review until it becomes Approved for Distribution
  • Number of review cycles: The average number of MLR review cycles per document (number of iterations)

Engagement channel definitions

  • In-person: Submitted calls with a CRM Standard Metrics call channel value of ¡®in-person¡¯
  • Phone: Submitted calls with a CRM Standard Metrics call channel value of ¡®phone¡¯
  • Video: ³Ô¹Ï±¬ÁÏ Engage calls and video calls via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®video¡¯
  • Email: Approved emails and emails sent via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®email¡¯
  • Chat or text: Submitted calls with a CRM Standard Metrics call channel value of ¡®chat or text¡¯

User type definitions

  • Sales: Users that have been classified with the ¡®sales¡¯ value in the CRM Standard Metrics user type field
  • Key account manager: Users that have been classified with the ¡®key account manager¡¯ value in the CRM Standard Metrics user type field
  • Medical: Users that have been classified with the ¡®medical¡¯ value in the CRM Standard Metrics user type field
  • Top pharma: Top 17 global pharma companies by revenue
  • Rest of industry: All other pharma companies

Region definitions

  • Global: All markets globally
  • Europe: Albania, Andorra, Armenia, Aruba, Austria, Azerbaijan, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, French Polynesia, Georgia, Germany, Greece, Greenland, Guadeloupe, Guernsey, Hungary, Ireland, Italy, Jersey, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Martinique, Republic of Moldova, Monaco, Montenegro, Netherlands, New Caledonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
  • Asia: Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, Cocos (Keeling) Islands, Indonesia, Japan, Kazakhstan, Republic of Korea, Kyrgyzstan, Malaysia, Mongolia, Myanmar, Nauru, Nepal, New Zealand, Philippines, Samoa, Singapore, Solomon Islands, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, Vietnam
  • Latin America: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Trinidad and Tobago, Uruguay, Venezuela

Methodology

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report is a quarterly industry benchmark for global and regional healthcare professional (HCP) engagement across the life sciences industry. The report is based on proprietary ³Ô¹Ï±¬ÁÏ Pulse data and insights from field engagement activities of more than 80% of all industry representatives worldwide (Asia Pacific, Europe, Latin America, and the United States). ³Ô¹Ï±¬ÁÏ CRM Standard Metrics ¡ª now used industrywide ¡ª provides the basis for consistent collection and measurement of engagement KPIs including channel mix and productivity across regions, roles, and market segments. The findings are based on approximately 600 million annual global field activities captured in ³Ô¹Ï±¬ÁÏ CRM and ³Ô¹Ï±¬ÁÏ CRM Engage, as well as ³Ô¹Ï±¬ÁÏ Pulse Content Metrics, the first and only industry benchmark for commercial content performance based on real-world anonymized data collected across 350+ global pharma companies. The findings are also based on 42+ billion prescription (Rx) and medical (Mx) records captured in ³Ô¹Ï±¬ÁÏ Compass, a U.S.-based longitudinal patient claims data set.

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report delivers insights that inform the industry and help field teams align their strategy to key market trends for improved commercial success. The global ³Ô¹Ï±¬ÁÏ Business Consulting team also helps customers inform their strategies using industry benchmarking with ³Ô¹Ï±¬ÁÏ Pulse data.

Let's Partner

Interested in learning more about
how ³Ô¹Ï±¬ÁÏ can help?

Contact Us Download PDF
Join the Conversation in ³Ô¹Ï±¬ÁÏ Connect

Where customers and ³Ô¹Ï±¬ÁÏ product leaders share information and ideas

³Ô¹Ï±¬ÁÏ Logo

Software, AI, Data, and Consulting for the Global Life Sciences Industry

? Copyright 2026 ³Ô¹Ï±¬ÁÏ Systems

Global Headquarters

Follow Us on Social

Demo Center Contact ³Ô¹Ï±¬ÁÏ

Solutions

  • Clinical
  • Regulatory
  • Safety
  • Quality
  • Medical
  • Commercial
  • Industry Segments

Services

  • Business Consulting

Partners

  • Service Partners
  • Product Partners
  • AI Partners
  • Content Partners
  • CRO Partners
  • Data Partners

Resources

  • Customer Stories
  • Resource Center
  • Events
  • News & Press
  • Blog

About ³Ô¹Ï±¬ÁÏ

  • Leadership
  • Public Benefit Corporation
  • Corporate Citizenship
  • Diversity at ³Ô¹Ï±¬ÁÏ
  • Trust

Global Headquarters

Follow Us on Social

Do Not Sell or Share My Personal Information Privacy Notice Terms Site Map